Results 11 to 20 of about 16,198,215 (212)

Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach

open access: yesAddictive Behaviors Reports, 2017
Introduction: Opioid use disorder (OUD) is characterized by a problematic pattern of opioid use leading to clinically-significant impairment or distress.
Earl B. Ettienne   +8 more
doaj   +4 more sources

Use and Outcomes of Medication for Opioid Use Disorder Among Patients With Opioid Use Disorder Undergoing Surgery

open access: yesAnnals of Surgery Open
Objective:. We examined patterns of use of perioperative medication for opioid use disorder (MOUD) in patients undergoing surgical procedures and assessed the association between MOUD use and perioperative opioid use and postsurgical adverse events ...
Alicia H. Li, MD   +7 more
doaj   +2 more sources

Management of Patients With Opioid Use Disorder (OUD). [PDF]

open access: yesCureus
Managing patients with opioid use disorder (OUD) presents a critical challenge in the perioperative setting. Due to challenges like opioid-induced hyperalgesia (OIH), withdrawal and relapse risks, and altered opioid pharmacodynamics, traditional pain management strategies may be inadequate or even counterproductive.
Martin-Orr N, Yun S.
europepmc   +4 more sources

Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians. [PDF]

open access: yesJ Gen Intern Med, 2023
During the pandemic, there was a dramatic shift to telemedicine for opioid use disorder (OUD) treatment. Little is known about how clinician attitudes about telemedicine use for OUD treatment are evolving or their preferences for future use.To understand OUD clinician views of and preferences regarding telemedicine.Longitudinal survey (wave 1, December
Huskamp HA   +6 more
europepmc   +3 more sources

A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD). [PDF]

open access: yesJ Med Toxicol, 2022
Despite the evidence in support of the use of buprenorphine in the treatment of OUD and increasing ability of emergency medicine (EM) clinicians to prescribe it, emergency department (ED)-initiated buprenorphine is uncommon. Many EM clinicians lack training on how to manage acute opioid withdrawal or initiate treatment with buprenorphine.
Khatri UG   +6 more
europepmc   +3 more sources

The Effect of Opioid Abatement Funds on the Utilization of Medications for Opioid Use Disorder. [PDF]

open access: yesHealth Serv Res
ABSTRACT Objective To evaluate whether opioid abatement fund allocations to treatment programs influence the utilization of medications for opioid use disorder (MOUD). Study Setting and Design The study employed a synthetic difference‐in‐differences design and a triple‐differences model using a state‐year panel to estimate the effects of abatement fund
Shi JS, Wen H.
europepmc   +2 more sources

Opioid Use Disorder (OUD) and Pregnancy in Utah [PDF]

open access: yes, 2021
Over the past twenty years, opioid use during pregnancy has become much more common (Haight et al., 2018). Opioids may be prescribed for pain management or the treatment of an opioid use disorder (OUD).
Madden, Erin Fanning   +6 more
core   +1 more source

A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings. [PDF]

open access: yesHarm Reduct J
In 2019, the state of Maryland passed legislation requiring local detention centers to offer medications for opioid use disorder (MOUD) to all incarcerated individuals who met criteria for opioid use disorder (OUD). Four years later, many facilities remain out of compliance.
McLean KJ   +9 more
europepmc   +4 more sources

Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study

open access: yesAddiction Science & Clinical Practice, 2023
Background Acute care inpatient admissions outside of psychiatric facilities have been increasingly identified as a critical touchpoint for opioid use disorder (OUD) treatment.
Sudha R. Raman   +5 more
doaj   +1 more source

Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine. [PDF]

open access: yesCurr Neuropharmacol, 2020
Background: Over 100 people die daily from opioid overdose and $78.5B per year is spent on treatment efforts, however, the real societal cost is multifold greater. Alternative strategies to eradicate/manage drug misuse and addiction need consideration.
Abijo T, Blum K, Gondré-Lewis MC.
europepmc   +4 more sources

Home - About - Disclaimer - Privacy